Company profile

Ticker
ABT
Exchange
Website
CEO
Robert B. Ford
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
360698440

ABT stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

29 Jul 20
20 Sep 20
31 Dec 20

News

Quarter (USD) Jun 20 Mar 20 Sep 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
11 Sep 20 Randel William Woodgrift Common shares without par value Sell Dispose S No 105.28 2,500 263.2K 46,267
1 Sep 20 Roger Bird Common shares without par value Sell Dispose S No 108.7328 6,290 683.93K 56,630
1 Sep 20 John F Ginascol Common shares without par value Payment of exercise Dispose F No 109.47 47,772 5.23M 89,003
1 Sep 20 John F Ginascol Common shares without par value Option exercise Aquire M No 44.4 39,953 1.77M 136,775
1 Sep 20 John F Ginascol Common shares without par value Option exercise Aquire M No 38.4 20,133 773.11K 96,822
1 Sep 20 John F Ginascol Common shares without par value Option exercise Aquire M No 47 12,012 564.56K 76,689
1 Sep 20 John F Ginascol Option Common shares Option exercise Dispose M No 44.4 39,953 1.77M 0
1 Sep 20 John F Ginascol Option Common shares Option exercise Dispose M No 38.4 20,133 773.11K 0
1 Sep 20 John F Ginascol Option Common shares Option exercise Dispose M No 47 12,012 564.56K 45,709
27 Aug 20 John M Capek Common shares without par value Sell Dispose S No 111.86 52,300 5.85M 316,800
72.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2172 2087 +4.1%
Opened positions 187 107 +74.8%
Closed positions 102 166 -38.6%
Increased positions 858 831 +3.2%
Reduced positions 846 887 -4.6%
13F shares
Current Prev Q Change
Total value 117.79B 102.82B +14.6%
Total shares 1.29B 1.3B -0.9%
Total puts 6M 5.48M +9.4%
Total calls 6.2M 6.7M -7.4%
Total put/call ratio 1.0 0.8 +18.2%
Largest owners
Shares Value Change
Vanguard 150.04M $13.72B -3.7%
BLK BlackRock 134.75M $12.32B +5.2%
Capital Research Global Investors 87.42M $7.99B -8.8%
STT State Street 74.56M $6.82B +0.6%
Capital International Investors 56.71M $5.18B +1.7%
Wellington Management 35.93M $3.28B -16.8%
NTRS Northern Trust 27.03M $2.47B +0.9%
Geode Capital Management 25.24M $2.3B +1.6%
BAC Bank of America 25.09M $2.29B -5.0%
MS Morgan Stanley 24.8M $2.27B -2.2%
Largest transactions
Shares Bought/sold Change
Capital Research Global Investors 87.42M -8.45M -8.8%
Wellington Management 35.93M -7.26M -16.8%
BLK BlackRock 134.75M +6.62M +5.2%
Vanguard 150.04M -5.75M -3.7%
Fisher Asset Management 6.9M +3.34M +93.7%
Ninety One UK 2.91K -3.09M -99.9%
GS Goldman Sachs 8.78M -3.06M -25.9%
Massachusetts Financial Services 24.46M -2.92M -10.7%
Ubs Global Asset Management Americas 8.39M -2.9M -25.7%
GQG Partners 12.53M +2.84M +29.3%

Financial report summary

?
Risks
  • The manufacture of many of Abbott’s products is a highly exacting and complex process, and if Abbott or one of its suppliers encounters problems manufacturing products, Abbott’s business could suffer.
Management Discussion
  • The increase in Total Net Sales in 2019 reflects volume growth across all of Abbott’s segments.  The increase in Total Net Sales in 2018 reflects the acquisition of Alere, as well as volume growth across all of Abbott’s segments.  The price declines related to the Medical Devices segment in 2019 and 2018 primarily reflect pricing pressures on drug eluting stents (DES) as a result of market competition in the U.S. and other major markets.
  • A comparison of significant product and product group sales is as follows.  Percent changes are versus the prior year and are based on unrounded numbers.
  • n/m = percent change is not meaningful.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: app, began, Bluetooth, children, clearance, defibrillator, Encouragingly, environment, Gallant, iCGM, Indenture, large, lifted, mitigate, mix, older, oral, Panbio, phase, rehydration, repair, repay, rotational, saving, senior, settlement, smartphone, strong, TriClip, tricuspid, uncertain, unpredictability, vast
Removed: advanced, Assist, flat, grew, HeartMate, Left, living, marketing, negative, people, Ventricular

Patents

APP
Utility
Navigational Reference Dislodgement Detection Method and System
17 Sep 20
A method of tracking a position of a catheter within a patient includes securing a navigational reference at a reference location within the patient, defining the reference location as the origin of a coordinate system, determining a location of an electrode moving within the patient relative to that coordinate system, monitoring for a dislodgement of the navigational reference from the initial reference location, for example by measuring the navigational reference relative to a far field reference outside the patient's body, and generating a signal indicating that the navigational reference has dislodged from the reference location.
APP
Utility
Arterial Imaging and Assessment Systems and Methods and Related User Interface Based-Workflows
17 Sep 20
In part, the disclosure relates to method of displaying a representation of an artery.
APP
Utility
Biostimulator Having Coaxial Fixation Elements
17 Sep 20
A biostimulator, such as a leadless cardiac pacemaker, including coaxial fixation elements to engage or electrically stimulate tissue, is described.
APP
Utility
Flow Cytometry Systems and Methods for Blocking Diffraction Patterns
17 Sep 20
Flow cytometer systems are provided having intermediate angle scatter detection capability.
APP
Utility
Aluminum Oxide Layer on Anode Foil for Aluminum Electrolytic Capacitor
17 Sep 20
A method of producing an oxide layer on a foil for use in a capacitor includes immersing the foil in a first solution; maintaining a target current between the immersed anodic foil and the first solution until a first target voltage is reached to form an oxide layer overlying the foil; maintaining the target current between the immersed foil and the first solution until a second target voltage is reached to reform the oxide layer; removing the foil from the first solution and heating the foil; immersing the heat treated foil in a second solution; maintaining the target current between the immersed foil and the second solution until a third target voltage is reached; and discharging the immersed foil after each of the first, second, and third target voltages are reached.